✦ LIBER ✦

Deramciclane in the treatment of generalized anxiety disorder: A placebo-controlled, double-blind, dose-finding study

✍ Scribed by Hannu Naukkarinen; Roope Raassina; Jukka Penttinen; Antti Ahokas; Riitta Jokinen; Hannu Koponen; Ulla Lepola; Harri Kanerva; Leena Lehtonen; Tiina Pohjalainen; Auli Partanen; Outi Mäki-Ikola; Juha Rouru

Book ID: 118436651
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 155 KB
Volume: 15
Category: Article
ISSN: 0924-977X
DOI: 10.1016/j.euroneuro.2005.03.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Deramciclane in the treatment of patient

Deramciclane in the treatment of patients with generalised anxiety disorder: A randomised, double-blind, placebo-controlled, dose-finding study

✍ H. Naukkarinen 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 275 KB

Escitalopram in the treatment of general

Escitalopram in the treatment of generalized anxiety disorder: Double-blind, placebo controlled, flexible-dose study

✍ Jonathan R.T. Davidson; Anjana Bose; Andrew Korotzer; Hongjie Zheng 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

Escitalopram has been shown in clinical trials to improve anxiety symptoms associated with depression, panic disorder, and social anxiety disorder. This study was designed to evaluate the efficacy and tolerability of escitalopram in the treatment of generalized anxiety disorder (GAD). Outpatients (1

Etizolam in the treatment of generalized

Etizolam in the treatment of generalized anxiety disorder: a double-blind study versus placebo

✍ Casacchia, Massimo; Bolino, Francesca; Ecari, Ugo 📂 Article 📅 1990 🏛 Informa plc 🌐 English ⚖ 552 KB

A randomized double-blind placebo-contro

A randomized double-blind placebo-controlled study of tropisetron in the treatment of outpatients with generalized anxiety disorder

✍ Y. Lecrubier; A. J. Puech; A. Azcona; P. E. Bailey; X. Lataste 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 594 KB

P.4.025 Tiagabine in generalized anxiety

P.4.025 Tiagabine in generalized anxiety disorder: a randomized, double-blind, placebo-controlled study

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Alprazolam in the treatment of generaliz

Alprazolam in the treatment of generalized anxiety and panic disorders: A double-blind placebo-controlled study

✍ G. Chouinard; L. Annable; R. Fontaine; L. Solyom 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 472 KB

In a double-blind controlled study lasting 8 weeks, 50 anxious psychoneurotic outpatients with a primary diagnosis of generalized anxiety or panic disorder were randomly assigned to alprazolam (n = 30), a new benzodiazepine, or placebo (n = 20), after a washout period of 1 week. Alprazolam at dosage